ArticleChemical & biomedical imaging2026
Donor-Acceptor Bridging via Twisted Quasi-Double-Bond: A Facile Design Strategy for Typical NIR-II AIEgen with "Simple" Structure.
Article in Chemical & biomedical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A facile design strategy for NIR-II fluorophores with aggregation-induced emission (AIE) characteristics was presented. This kind of NIR-II AIE luminogen, TSPCI is an example, is by the strong acceptor-donor bridging via a twisted quasi-double-bond (TQDB). Theoretical calculations revealed that the introduction of TQDB was the major factor for quenching of the photoexcited TSPCI molecule in the solution state. TSPCI showed excellent NIR-II imaging performance for in vivo dynamic imaging with high contrast and penetration depth. TSPCI holds great potential as a building block to easily fabricate activatable fluorescent probes with superior responsive ability in the second NIR optical window for in vivo imaging applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.